Detalhe da pesquisa
1.
Sonrotoclax overcomes BCL2 G101V mutation-induced venetoclax resistance in preclinical models of hematologic malignancy.
Blood;
143(18): 1825-1836, 2024 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38211332
2.
Chrysin inhibits hepatocellular carcinoma progression through suppressing programmed death ligand 1 expression.
Phytomedicine;
95: 153867, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34923234